Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Spherix Inc is a United States-based biotechnology company. The company is engaged in the development of small-molecule anti-cancer therapeutics. The company's drug portfolio includes therapies for pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL). Spherix Inc is a United States-based biotechnology company. The company is engaged in the development of small-molecule anti-cancer therapeutics. The company's drug portfolio includes therapies for pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL).
AIkido Pharma Appoints Dr. Scott T. Tagawa, M.D. to Scientific Advisory Board PR Newswire NEW YORK, Feb. 3, 2021 NEW YORK, Feb. 3, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido...
Aikido Pharma Secures Early Interest in Next Generation Radiotherapy Currently in Human Phase 2 Trials for Treatment of Prostate Cancer PR Newswire NEW YORK, Feb. 1, 2021 NEW YORK, Feb. 1, 2021...
Company Signs Long-term Supply Agreement for Pharmaceutical D-tagatose BETHESDA, Md., Jan. 12 /PRNewswire-FirstCall/ -- Spherix Inc. (Nasdaq SPEX), an innovator in biotechnology for diabetes...
BETHESDA, Md., Jan. 11 /PRNewswire-FirstCall/ -- Spherix Inc. (NASDAQ: SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services...
BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting...
BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting...
BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting...
BETHESDA, Md., Sept 10 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting...
BETHESDA, Md., Sept. 3 /PRNewswire-FirstCall/ -- Spherix Inc. (NASDAQ: SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services...
Preliminary Data Demonstrates Reduction of HbA1c Levels With Doses an Order of Magnitude Lower than the Dose Used in the Current Phase 3 Trial. BETHESDA, Md., June 24 /PRNewswire-FirstCall/...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
